Kathleen Petrillo Quoted in "The Pink Sheet"

Download a PDF | Get Acrobat

In the April 11, 2008 issue of "The Pink Sheet," attorney Kathleen Petrillo comments on a recent court decision granting Teva Pharmaceuticals 180 days of market exclusivity for a generic version of the schizophrenia drug Risperdal (risperidone).

Teva was the first firm to file an Abbreviated New Drug Application (ANDA) with the FDA while the patent, owned by Johnson & Johnson, was still listed. Therefore, Ms. Petrillo notes, "I think Teva had a good case...The timing seems right for what Teva did. They were first in line." She adds that as more drugs lose patent protection, conflicts over generics are "likely to be a very active area of the law."

"The Pink Sheet" is a leading weekly publication covering the prescription pharmaceutical and biotechnology industries.

Ms. Petrillo's practice focuses on chemical and life sciences.




Home Our Firm History In the Community Representative Clients Irving Powers Attorneys Practice Areas Patent Practice Trademark Practice Copyright Practice Litigation Practice News & Events Resources Senniger Perspectives Industry Perspectives Case Summaries Relevant Links Careers Compensation Summer Associate Program Diversity Interview with Us About St. Louis Contact Site Map

		Kathleen Petrillo Quoted in "The Pink Sheet" Download a PDF \| Get Acrobat In the April 11, 2008 issue of "The Pink Sheet," attorney Kathleen Petrillo comments on a recent court decision granting Teva Pharmaceuticals 180 days of market exclusivity for a generic version of the schizophrenia drug Risperdal (risperidone). Teva was the first firm to file an Abbreviated New Drug Application (ANDA) with the FDA while the patent, owned by Johnson & Johnson, was still listed. Therefore, Ms. Petrillo notes, "I think Teva had a good case...The timing seems right for what Teva did. They were first in line." She adds that as more drugs lose patent protection, conflicts over generics are "likely to be a very active area of the law." "The Pink Sheet" is a leading weekly publication covering the prescription pharmaceutical and biotechnology industries. Ms. Petrillo's practice focuses on chemical and life sciences.

Home Firm Attorneys Practice Areas News & Events Resources Careers Contact Site Map

©2005-2008 Senniger Powers LLP All Rights Reserved Disclaimer Intellectual Property Including Patents, Trademarks, Copyright and Litigation